Prediction: Lilly Will Trade at Record High in 12 Months
Eli Lilly stock is surging on fresh obesity-drug data, fueling bets that the name could push toward a record high wit...
A straightforward rationale for incorporating Equal Weighted Indices into a portfolio, emphasizing diversification and simplicity.
22,501 articlesEli Lilly stock is surging on fresh obesity-drug data, fueling bets that the name could push toward a record high wit...
Eli Lilly's Q1 2026 results slam the lid on the GLP-1 duopoly's early calm, with Lilly’s revenue exploding and Novo N...
Bank on a nuclear surge in 2026? URNM and URA offer different routes to exposure. This piece breaks down urnm: which ...
SpaceX rolls out a $60 billion bid to acquire Cursor and back new silicon ventures, aiming to tilt the AI hardware la...
Elon Musk’s wealth narrowed dramatically after SpaceX’s IPO, underscoring how quickly fortunes hinge on a single comp...
As AI workloads surge, two very different cloud players stand out: Alphabet, with its diversified cloud platform, vs ...
Inflation is back, and 2026 could test investors in new ways. This guide breaks down what inflation surging: here's t...
Demi Moore reportedly lands a top per-episode rate, highlighting how big contracts affect seasons, taxes, and long-te...
A new MLP income ETF employs a covered call overlay to lift yield beyond AMLP, drawing attention from income-focused ...
A hypothetical SpaceX Nasdaq move could quietly lift required minimum distributions for retirees. This piece breaks d...
When a legendary actor steps into the music world, it isn’t just a career shift—it’s a case study in how creative inc...
As volatility climbs in 2026, SPYI and JEPI compete for monthly income. SPYI bets on higher yields with derivative in...